Specific	O
complex	O
formation	O
between	O
the	O
type	B-protein
II	I-protein
bare	I-protein
lymphocyte	I-protein
syndrome-associated	I-protein
transactivators	I-protein
CIITA	B-protein
and	O
RFX5	B-protein
.	O

Two	O
of	O
the	O
genes	O
defective	O
in	O
the	O
five	O
complementation	O
groups	O
identified	O
in	O
the	O
class	O
II-negative	O
bare	O
lymphocyte	O
syndrome	O
or	O
corresponding	O
laboratory	O
mutants	O
have	O
been	O
cloned	O
.	O

One	O
gene	O
encodes	O
a	O
protein	O
,	O
RFX5	B-protein
,	O
that	O
is	O
a	O
member	O
of	O
the	O
RFX	B-protein
family	I-protein
of	I-protein
DNA	I-protein
binding	I-protein
proteins	I-protein
.	O

The	O
other	O
,	O
CIITA	B-protein
,	O
encodes	O
a	O
large	O
protein	O
with	O
a	O
defined	O
acidic	B-protein
transcriptional	I-protein
activation	I-protein
domain	I-protein
;	O
this	O
protein	O
does	O
not	O
interact	O
with	O
DNA	O
.	O

Expression	B-DNA
plasmids	I-DNA
encoding	O
regions	O
of	O
RFX5	B-protein
fused	O
to	O
the	O
GAL4	B-protein
DNA	I-protein
binding	I-protein
domain	I-protein
activated	O
transcription	O
from	O
a	O
reporter	O
construct	O
containing	O
GAL4	B-DNA
sites	I-DNA
in	O
a	O
cotransfection	O
assay	O
in	O
the	O
Raji	B-cell_line
human	I-cell_line
B	I-cell_line
cell	I-cell_line
line	I-cell_line
.	O

However	O
,	O
these	O
plasmids	B-DNA
produced	O
transcriptional	O
activity	O
in	O
HeLa	B-cell_line
cells	I-cell_line
only	O
in	O
conjunction	O
with	O
interferon	B-protein
gamma	I-protein
stimulation	O
,	O
a	O
condition	O
in	O
which	O
expression	O
of	O
both	O
CIITA	B-protein
and	O
class	B-protein
II	I-protein
major	I-protein
histocompatibility	I-protein
complex	I-protein
surface	I-protein
proteins	I-protein
are	O
induced	O
.	O

Furthermore	O
,	O
these	O
plasmids	B-DNA
were	O
not	O
active	O
in	O
RJ2.2.5	B-cell_line
,	O
an	O
in	O
vitro	O
mutagenized	O
derivative	O
of	O
Raji	B-cell_line
in	O
which	O
both	O
copies	O
of	O
CIITA	B-protein
are	O
defective	O
.	O

Transcriptional	O
activation	O
by	O
the	O
RFX5	B-protein
fusion	I-protein
protein	I-protein
could	O
be	O
restored	O
in	O
RJ2.2.5	B-cell_line
by	O
cotransfection	O
with	O
a	O
CIITA	B-DNA
expression	I-DNA
plasmid	I-DNA
.	O

Finally	O
,	O
a	O
direct	O
interaction	O
between	O
RFX5	B-protein
and	O
CIITA	B-protein
was	O
detected	O
with	O
the	O
yeast	O
two-hybrid	O
and	O
far-Western	O
blot	O
assays	O
.	O

Thus	O
,	O
RFX5	B-protein
can	O
activate	O
transcription	O
only	O
in	O
cooperation	O
with	O
CIITA	B-protein
.	O

RFX5	B-protein
and	O
CIITA	B-protein
associate	O
to	O
form	O
a	O
complex	O
capable	O
of	O
activating	O
transcription	O
from	O
class	B-DNA
II	I-DNA
major	I-DNA
histocompatibility	I-DNA
complex	I-DNA
promoters	I-DNA
.	O

In	O
this	O
complex	O
,	O
promoter	O
specificity	O
is	O
determined	O
by	O
the	O
DNA	O
binding	O
domain	O
of	O
RFX5	B-protein
and	O
the	O
general	O
transcription	O
apparatus	O
is	O
recruited	O
by	O
the	O
acidic	B-protein
activation	I-protein
domain	I-protein
of	O
CIITA	B-protein
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

94	NULL
,	NULL
pp	NULL
.	NULL

6330-6334	NULL
,	NULL
June	NULL
1997	NULL
Immunology	NULL
Specific	NULL
complex	NULL
formation	NULL
between	NULL
the	NULL
type	NULL
II	NULL
bare	NULL
lymphocyte	NULL
syndrome-associated	NULL
transactivators	NULL
CIITA	NULL
and	NULL
RFX5	NULL
THomas	NULL
ScHoLL*T	NULL
,	NULL
SaNIEEYV	NULL
K.	NULL
anD	NULL
JacK	NULL
L.	NULL
StRomiNnaErR	NULL
$	NULL
§	NULL
Department	NULL
of	NULL
Molecular	NULL
and	NULL
Cellular	NULL
Biology	NULL
,	NULL
Harvard	NULL
University	NULL
,	NULL
7	NULL
Divinity	NULL
Avenue	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
02138	NULL
Contributed	NULL
by	NULL
Jack	NULL
L.	NULL
Strominger	NULL
,	NULL
December	NULL
20	NULL
,	NULL
1997	NULL
ABSTRACT	NULL
Two	NULL
of	NULL
the	NULL
genes	NULL
defective	NULL
in	NULL
the	NULL
five	NULL
complementation	NULL
groups	NULL
identified	NULL
in	NULL
the	NULL
class	NULL
II-negative	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
or	NULL
corresponding	NULL
laboratory	NULL
mutants	NULL
have	NULL
been	NULL
cloned	NULL
.	NULL

One	NULL
gene	NULL
encodes	NULL
a	NULL
protein	NULL
,	NULL
RFX5	NULL
,	NULL
that	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
RFX	NULL
family	NULL
of	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

The	NULL
other	NULL
,	NULL
CIITA	NULL
,	NULL
encodes	NULL
a	NULL
large	NULL
protein	NULL
with	NULL
a	NULL
defined	NULL
acidic	NULL
transcriptional	NULL
activation	NULL
domain	NULL
;	NULL
this	NULL
protein	NULL
does	NULL
not	NULL
interact	NULL
with	NULL
DNA	NULL
.	NULL

Expression	NULL
plasmids	NULL
encoding	NULL
regions	NULL
of	NULL
RFXS5	NULL
fused	NULL
to	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
activated	NULL
transcription	NULL
from	NULL
a	NULL
reporter	NULL
construct	NULL
containing	NULL
GAL4	NULL
sites	NULL
in	NULL
a	NULL
cotransfection	NULL
assay	NULL
in	NULL
the	NULL
Raji	NULL
human	NULL
B	NULL
cell	NULL
line	NULL
.	NULL

However	NULL
,	NULL
these	NULL
plasmids	NULL
produced	NULL
transcriptional	NULL
activity	NULL
in	NULL
HeLa	NULL
cells	NULL
only	NULL
in	NULL
conjunction	NULL
with	NULL
interferon	NULL
y	NULL
stimulation	NULL
,	NULL
a	NULL
condition	NULL
in	NULL
which	NULL
expression	NULL
of	NULL
both	NULL
CIITA	NULL
and	NULL
class	NULL
II	NULL
major	NULL
histocompatibility	NULL
complex	NULL
surface	NULL
proteins	NULL
are	NULL
in-duced	NULL
.	NULL

Furthermore	NULL
,	NULL
these	NULL
plasmids	NULL
were	NULL
not	NULL
active	NULL
in	NULL
RJ2.2.5	NULL
,	NULL
an	NULL
in	NULL
vitro	NULL
mutagenized	NULL
derivative	NULL
of	NULL
Raji	NULL
in	NULL
which	NULL
both	NULL
copies	NULL
of	NULL
CIITA	NULL
are	NULL
defective	NULL
.	NULL

Transcriptional	NULL
activation	NULL
by	NULL
the	NULL
RFX5	NULL
fusion	NULL
protein	NULL
could	NULL
be	NULL
restored	NULL
in	NULL
RJ2.2.5	NULL
by	NULL
cotransfection	NULL
with	NULL
a	NULL
CIITA	NULL
expression	NULL
plasmid	NULL
.	NULL

Finally	NULL
,	NULL
a	NULL
direct	NULL
interaction	NULL
between	NULL
RFX5	NULL
and	NULL
CIITA	NULL
was	NULL
detected	NULL
with	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
and	NULL
far-Western	NULL
blot	NULL
assays	NULL
.	NULL

Thus	NULL
,	NULL
RFX5	NULL
can	NULL
activate	NULL
transcription	NULL
only	NULL
in	NULL
cooperation	NULL
with	NULL
CIITA	NULL
.	NULL

RFXS5	NULL
and	NULL
CIITA	NULL
associate	NULL
to	NULL
form	NULL
a	NULL
complex	NULL
capable	NULL
of	NULL
activating	NULL
transcription	NULL
from	NULL
class	NULL
II	NULL
major	NULL
histocompatibility	NULL
complex	NULL
promoters	NULL
.	NULL

In	NULL
this	NULL
complex	NULL
,	NULL
promoter	NULL
specificity	NULL
is	NULL
determined	NULL
by	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
RFX5S	NULL
and	NULL
the	NULL
general	NULL
transcription	NULL
apparatus	NULL
is	NULL
recruited	NULL
by	NULL
the	NULL
acidic	NULL
activation	NULL
domain	NULL
of	NULL
CIITA	NULL
.	NULL

Type	NULL
II	NULL
combined	NULL
immunodeficiency	NULL
or	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
(	NULL
BLS	NULL
)	NULL
is	NULL
a	NULL
rare	NULL
congenital	NULL
disease	NULL
characterized	NULL
by	NULL
a	NULL
lack	NULL
of	NULL
transcription	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
(	NULL
MHC	NULL
)	NULL
class	NULL
II	NULL
genes	NULL
(	NULL
1	NULL
)	NULL
.	NULL

BLS	NULL
patients	NULL
fall	NULL
into	NULL
three	NULL
genetic	NULL
complementation	NULL
groups	NULL
and	NULL
an	NULL
in	NULL
vifro	NULL
mutant	NULL
defined	NULL
a	NULL
fourth	NULL
(	NULL
2-5	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
a	NULL
potential	NULL
fifth	NULL
complementation	NULL
group	NULL
has	NULL
been	NULL
reported	NULL
.	NULL

The	NULL
atypical	NULL
phenotype	NULL
of	NULL
these	NULL
latter	NULL
patients	NULL
exhibited	NULL
discoordi-nate	NULL
regulation	NULL
between	NULL
a	NULL
and	NULL
chains	NULL
and	NULL
low	NULL
levels	NULL
of	NULL
class	NULL
II	NULL
surface	NULL
expression	NULL
on	NULL
some	NULL
cell	NULL
types	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

Transacting	NULL
factors	NULL
are	NULL
responsible	NULL
for	NULL
these	NULL
various	NULL
defects	NULL
since	NULL
fusion	NULL
of	NULL
B	NULL
cell	NULL
lines	NULL
derived	NULL
from	NULL
patients	NULL
with	NULL
those	NULL
from	NULL
a	NULL
patient	NULL
representing	NULL
a	NULL
different	NULL
complementation	NULL
group	NULL
or	NULL
with	NULL
a	NULL
normal	NULL
cell	NULL
line	NULL
restores	NULL
class	NULL
II	NULL
expression	NULL
.	NULL

The	NULL
defective	NULL
genes	NULL
in	NULL
two	NULL
of	NULL
the	NULL
complementation	NULL
groups	NULL
have	NULL
been	NULL
cloned	NULL
.	NULL

Class	NULL
II	NULL
MHC	NULL
trans-activator	NULL
(	NULL
CIITA	NULL
)	NULL
is	NULL
defective	NULL
in	NULL
patients	NULL
from	NULL
complementation	NULL
group	NULL
A	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Transfection	NULL
experiments	NULL
with	NULL
plasmids	NULL
expressing	NULL
wild-type	NULL
CIITA	NULL
rescued	NULL
MHC	NULL
class	NULL
II	NULL
expression	NULL
in	NULL
three	NULL
cell	NULL
lines	NULL
from	NULL
this	NULL
group	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
cell	NULL
lines	NULL
from	NULL
this	NULL
group	NULL
carry	NULL
mutations	NULL
in	NULL
both	NULL
copies	NULL
of	NULL
the	NULL
CIITA	NULL
gene	NULL
.	NULL

Unlike	NULL
other	NULL
factors	NULL
reported	NULL
to	NULL
regulate	NULL
class	NULL
II	NULL
MHC	NULL
transcription	NULL
for	NULL
which	NULL
genes	NULL
have	NULL
been	NULL
cloned	NULL
and	NULL
which	NULL
have	NULL
all	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
ubiquitously	NULL
transcribed	NULL
DNA	NULL
binding	NULL
proteins	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
,	NULL
the	NULL
mes	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1997	NULL
by	NULL
The	NULL
National	NULL
Academy	NULL
of	NULL
Sciences	NULL
0027-8424	NULL
/97/946330-5	NULL
$	NULL
2.00/0	NULL
6330	NULL
sage	NULL
for	NULL
CHHTA	NULL
correlates	NULL
with	NULL
class	NULL
II	NULL
MHC	NULL
expression	NULL
in	NULL
cell	NULL
lines	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
this	NULL
correlation	NULL
extends	NULL
to	NULL
interferon	NULL
y	NULL
(	NULL
IFN-y	NULL
)	NULL
-inducible	NULL
expression	NULL
and	NULL
developmental	NULL
extinction	NULL
in	NULL
plasma	NULL
cells	NULL
since	NULL
in	NULL
both	NULL
cases	NULL
induced	NULL
expression	NULL
of	NULL
CIITA	NULL
alone	NULL
causes	NULL
class	NULL
II	NULL
MHC	NULL
expression	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
results	NULL
strongly	NULL
suggest	NULL
that	NULL
while	NULL
several	NULL
transcription	NULL
factors	NULL
are	NULL
required	NULL
for	NULL
class	NULL
II	NULL
MHC	NULL
expression	NULL
,	NULL
CIITA	NULL
is	NULL
the	NULL
specific	NULL
regulator	NULL
that	NULL
controls	NULL
both	NULL
developmental	NULL
and	NULL
inducible	NULL
class	NULL
II	NULL
MHC	NULL
gene	NULL
expression	NULL
.	NULL

CIITA	NULL
does	NULL
not	NULL
bind	NULL
DNA	NULL
but	NULL
does	NULL
contain	NULL
two	NULL
functional	NULL
domains	NULL
.	NULL

The	NULL
N	NULL
terminus	NULL
encodes	NULL
an	NULL
acidic	NULL
transcriptional	NULL
activator	NULL
,	NULL
and	NULL
the	NULL
C	NULL
terminus	NULL
targets	NULL
the	NULL
protein	NULL
to	NULL
MHC	NULL
class	NULL
II	NULL
promoters	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
acidic	NULL
activator	NULL
is	NULL
not	NULL
specific	NULL
for	NULL
class	NULL
II	NULL
transcription	NULL
and	NULL
the	NULL
function	NULL
of	NULL
this	NULL
domain	NULL
can	NULL
be	NULL
replaced	NULL
with	NULL
an	NULL
activation	NULL
domain	NULL
from	NULL
a	NULL
viral	NULL
protein	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

The	NULL
gene	NULL
for	NULL
RFX5	NULL
,	NULL
defective	NULL
in	NULL
complementation	NULL
group	NULL
B	NULL
,	NULL
was	NULL
cloned	NULL
by	NULL
the	NULL
same	NULL
approach	NULL
as	NULL
CIITA	NULL
(	NULL
15	NULL
)	NULL
.	NULL

RFXS	NULL
shares	NULL
homology	NULL
with	NULL
a	NULL
family	NULL
of	NULL
DNA	NULL
binding	NULL
proteins	NULL
(	NULL
RFX1-4	NULL
)	NULL
,	NULL
a	NULL
member	NULL
of	NULL
which	NULL
was	NULL
initially	NULL
misidentified	NULL
as	NULL
the	NULL
factor	NULL
responsible	NULL
for	NULL
the	NULL
BLS	NULL
defect	NULL
(	NULL
16	NULL
)	NULL
but	NULL
was	NULL
subsequently	NULL
reported	NULL
to	NULL
regulate	NULL
hepatitis	NULL
B	NULL
virus	NULL
enhancer	NULL
activity	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Two	NULL
B	NULL
cell	NULL
lines	NULL
derived	NULL
from	NULL
BLS	NULL
patients	NULL
in	NULL
complementation	NULL
group	NULL
B	NULL
have	NULL
defective	NULL
RFXS5	NULL
loci	NULL
on	NULL
both	NULL
chro-mosomes	NULL
,	NULL
and	NULL
class	NULL
II	NULL
MHC	NULL
expression	NULL
can	NULL
be	NULL
rescued	NULL
in	NULL
these	NULL
lines	NULL
by	NULL
transfection	NULL
of	NULL
an	NULL
expression	NULL
plasmid	NULL
encoding	NULL
wild-type	NULL
RFXS5	NULL
(	NULL
15	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
RFXS	NULL
in	NULL
class	NULL
II	NULL
transcription	NULL
is	NULL
also	NULL
supported	NULL
by	NULL
its	NULL
specific	NULL
binding	NULL
to	NULL
a	NULL
conserved	NULL
class	NULL
II	NULL
promoter	NULL
element	NULL
,	NULL
the	NULL
X	NULL
box	NULL
,	NULL
and	NULL
its	NULL
presence	NULL
in	NULL
nuclear	NULL
complexes	NULL
which	NULL
form	NULL
on	NULL
the	NULL
DRA	NULL
promoter	NULL
in	NULL
electro-phoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Herein	NULL
,	NULL
deletion	NULL
mutagenesis	NULL
demonstrates	NULL
the	NULL
regions	NULL
of	NULL
RFXS5	NULL
that	NULL
are	NULL
required	NULL
for	NULL
activating	NULL
transcription	NULL
in	NULL
a	NULL
B	NULL
cell	NULL
line	NULL
.	NULL

However	NULL
,	NULL
in	NULL
HeLa	NULL
cells	NULL
this	NULL
activity	NULL
is	NULL
detected	NULL
only	NULL
after	NULL
IFN-y	NULL
stimulation	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
a	NULL
cell	NULL
that	NULL
is	NULL
defective	NULL
in	NULL
CIITA	NULL
,	NULL
this	NULL
region	NULL
of	NULL
RFXS5	NULL
is	NULL
only	NULL
functional	NULL
after	NULL
genetic	NULL
complementation	NULL
with	NULL
a	NULL
CIITA	NULL
expression	NULL
plasmid	NULL
.	NULL

Finally	NULL
,	NULL
a	NULL
direct	NULL
interaction	NULL
between	NULL
RFXS	NULL
and	NULL
CIITA	NULL
was	NULL
detected	NULL
in	NULL
vivo	NULL
with	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
assay	NULL
and	NULL
in	NULL
vitro	NULL
by	NULL
direct	NULL
protein-protein	NULL
interaction	NULL
with	NULL
a	NULL
far-Western	NULL
blot	NULL
analysis	NULL
.	NULL

Thus	NULL
,	NULL
RFXS	NULL
activates	NULL
transcription	NULL
indirectly	NULL
by	NULL
recruitment	NULL
of	NULL
CIITA	NULL
specifically	NULL
to	NULL
the	NULL
class	NULL
II	NULL
MHC	NULL
promoter	NULL
where	NULL
the	NULL
previously	NULL
characterized	NULL
N-terminal	NULL
acidic	NULL
domain	NULL
of	NULL
CIITA	NULL
serves	NULL
to	NULL
activate	NULL
transcription	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Isolation	NULL
of	NULL
CIITA	NULL
and	NULL
RFX5	NULL
cDNAs	NULL
and	NULL
Construction	NULL
of	NULL
Plasmids	NULL
.	NULL

Raji	NULL
cDNA	NULL
was	NULL
prepared	NULL
by	NULL
commercial	NULL
mRNA	NULL
isolation	NULL
(	NULL
Oligotex	NULL
,	NULL
Qiagen	NULL
,	NULL
Chatsworth	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
synthesis	NULL
Abbreviations	NULL
:	NULL
IFN-y	NULL
,	NULL
interferon	NULL
y	NULL
,	NULL
MHC	NULL
,	NULL
major	NULL
histocompatibility	NULL
complex	NULL
;	NULL
BLS	NULL
,	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
.	NULL

*T.S	NULL
.	NULL

and	NULL
S.K.M	NULL
.	NULL

contributed	NULL
equally	NULL
to	NULL
this	NULL
work	NULL
.	NULL

TPresent	NULL
address	NULL
:	NULL
Myriad	NULL
Genetic	NULL
Laboratories	NULL
,	NULL
320	NULL
Wakara	NULL
Way	NULL
,	NULL
Salt	NULL
Lake	NULL
City	NULL
,	NULL
UT	NULL
84108.	NULL
address	NULL
:	NULL
Skirball	NULL
Institute	NULL
of	NULL
Biomolecular	NULL
Medicine	NULL
,	NULL
NYU	NULL
Medical	NULL
Center	NULL
,	NULL
540	NULL
First	NULL
Avenue	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
10016	NULL
.	NULL

$	NULL
To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Immunology	NULL
:	NULL
Scholl	NULL
et	NULL
al	NULL
.	NULL

kits	NULL
(	NULL
Stratascript	NULL
,	NULL
Stratagene	NULL
)	NULL
.	NULL

This	NULL
cDNA	NULL
and	NULL
oligonucleo-tides	NULL
(	NULL
GIBCO/BRL	NULL
)	NULL
for	NULL
CHITA	NULL
,	NULL
CIITA.1	NULL
(	NULL
ATAGAATTCG-CAGCTGGAGAGGTCTCCAAC	NULL
;	NULL
contains	NULL
EcoRI	NULL
adapter	NULL
underlined	NULL
)	NULL
and	NULL
CIITA.Z2	NULL
(	NULL
ATACTCGAGTCTCAGGCT-GATCCGTGAATC	NULL
;	NULL
contains	NULL
Xhol	NULL
adapter	NULL
underlined	NULL
)	NULL
;	NULL
for	NULL
RFX5	NULL
,	NULL
RFXS5.1	NULL
(	NULL
GTGGCTACGAGTTTTCCAGATT	NULL
)	NULL
and	NULL
RFXS5.2	NULL
(	NULL
GGAATACAGGTAAGGTCACTAC	NULL
)	NULL
were	NULL
employed	NULL
in	NULL
the	NULL
PCR	NULL
using	NULL
pfu	NULL
DNA	NULL
polymerase	NULL
(	NULL
Stratagene	NULL
)	NULL
to	NULL
isolate	NULL
the	NULL
CIITA	NULL
and	NULL
RFXS	NULL
coding	NULL
regions	NULL
.	NULL

These	NULL
fragments	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
EcoRI	NULL
and	NULL
Xhol	NULL
sites	NULL
of	NULL
pBluescript	NULL
II	NULL
KS+	NULL
for	NULL
CIITA	NULL
and	NULL
designated	NULL
pBSCIITA	NULL
or	NULL
cloned	NULL
into	NULL
the	NULL
SmaI	NULL
site	NULL
for	NULL
RFXS5	NULL
and	NULL
designated	NULL
pBSRFXS5	NULL
.	NULL

For	NULL
mammalian	NULL
expression	NULL
and	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
system	NULL
,	NULL
the	NULL
CIITA	NULL
coding	NULL
region	NULL
was	NULL
inserted	NULL
into	NULL
pBKCMV	NULL
(	NULL
Stratagene	NULL
)	NULL
from	NULL
which	NULL
the	NULL
lee	NULL
promoter	NULL
had	NULL
been	NULL
deleted	NULL
and	NULL
designated	NULL
pCMVCIITA	NULL
and	NULL
into	NULL
pGAD424	NULL
(	NULL
CLONTECH	NULL
)	NULL
in	NULL
frame	NULL
with	NULL
the	NULL
Gal4	NULL
activation	NULL
domain	NULL
and	NULL
designated	NULL
pGADCIITA	NULL
.	NULL

Deletions	NULL
of	NULL
the	NULL
RFXS	NULL
coding	NULL
sequence	NULL
were	NULL
cloned	NULL
in	NULL
frame	NULL
with	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
pBXG1	NULL
using	NULL
restriction	NULL
sites	NULL
KpnI	NULL
(	NULL
bp	NULL
273	NULL
)	NULL
for	NULL
essentially	NULL
full-length	NULL
pGAL-RFXA34	NULL
,	NULL
Xhol	NULL
(	NULL
bp	NULL
750	NULL
)	NULL
and	NULL
PstI	NULL
(	NULL
bp	NULL
1125	NULL
)	NULL
without	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
for	NULL
pGALRFXA194	NULL
and	NULL
pGALRFXA318	NULL
,	NULL
and	NULL
EcoRI	NULL
(	NULL
bp	NULL
1600	NULL
)	NULL
without	NULL
the	NULL
proline-rich	NULL
region	NULL
for	NULL
pGALRFXA477	NULL
.	NULL

The	NULL
RFXS	NULL
deletions	NULL
resulting	NULL
from	NULL
digestion	NULL
with	NULL
KpnI	NULL
,	NULL
Xhol	NULL
,	NULL
and	NULL
Pstl	NULL
were	NULL
also	NULL
inserted	NULL
into	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
expression	NULL
vector	NULL
pGBT9	NULL
and	NULL
designated	NULL
pG-BRFXA34	NULL
,	NULL
pGBRFXA194	NULL
,	NULL
and	NULL
pGBRFXA318	NULL
.	NULL

For	NULL
in	NULL
vitro	NULL
translation	NULL
the	NULL
Xhol	NULL
and	NULL
Psfl	NULL
derivatives	NULL
of	NULL
RFXS5	NULL
were	NULL
inserted	NULL
into	NULL
pCITE2a	NULL
(	NULL
Novagen	NULL
)	NULL
and	NULL
designated	NULL
pTLN-RFX5A194	NULL
and	NULL
pTLNRFX5A318	NULL
.	NULL

For	NULL
bacterial	NULL
expression	NULL
,	NULL
CIITA	NULL
regions	NULL
corresponding	NULL
to	NULL
residues	NULL
1-161	NULL
and	NULL
299-1129	NULL
were	NULL
cloned	NULL
into	NULL
pET15b	NULL
(	NULL
Novagen	NULL
)	NULL
and	NULL
designated	NULL
pHISCI-ITTAI-161	NULL
and	NULL
pHISCIITA299-1129	NULL
.	NULL

The	NULL
plasmid	NULL
pFUSE	NULL
contains	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
residues	NULL
1-147	NULL
)	NULL
in	NULL
pET15Sb	NULL
.	NULL

All	NULL
PCR	NULL
products	NULL
were	NULL
completely	NULL
sequenced	NULL
,	NULL
as	NULL
were	NULL
all	NULL
junctions	NULL
in	NULL
cloning	NULL
operations	NULL
(	NULL
Sequenase	NULL
,	NULL
United	NULL
States	NULL
Biochemical	NULL
)	NULL
.	NULL

Plasmids	NULL
pGSEC	NULL
,	NULL
pBXG1	NULL
,	NULL
pBXGAL-VP	NULL
,	NULL
and	NULL
pFUSE	NULL
were	NULL
the	NULL
generous	NULL
gift	NULL
of	NULL
Mark	NULL
Ptashne	NULL
.	NULL

Plasmids	NULL
pTD-1	NULL
and	NULL
pVa3	NULL
were	NULL
purchased	NULL
(	NULL
CLONTECH	NULL
)	NULL
.	NULL

Cell	NULL
Culture	NULL
and	NULL
Transfection	NULL
.	NULL

Raji	NULL
(	NULL
CCL	NULL
86	NULL
,	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
)	NULL
is	NULL
a	NULL
Burkitt	NULL
lymphoma	NULL
B	NULL
cell	NULL
line	NULL
that	NULL
expresses	NULL
all	NULL
MHC	NULL
class	NULL
II	NULL
isotypes	NULL
.	NULL

RJ2.2.5	NULL
was	NULL
derived	NULL
by	NULL
ry-irradiation	NULL
mutagenesis	NULL
of	NULL
Raji	NULL
and	NULL
is	NULL
defective	NULL
for	NULL
global	NULL
MHC	NULL
class	NULL
II	NULL
transcription	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
HeLa	NULL
cell	NULL
line	NULL
(	NULL
CCL	NULL
2	NULL
,	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
)	NULL
was	NULL
derived	NULL
from	NULL
a	NULL
cervical	NULL
carcinoma	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
and	NULL
treated	NULL
with	NULL
IFN-y	NULL
as	NULL
reported	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
amounts	NULL
of	NULL
plasmids	NULL
by	NULL
electroporation	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
PBS	NULL
with	NULL
10	NULL
mM	NULL
Hepes	NULL
(	NULL
pH	NULL
7.3	NULL
)	NULL
and	NULL
resuspended	NULL
at	NULL
4	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
per	NULL
ml	NULL
,	NULL
on	NULL
ice	NULL
.	NULL

Aliquots	NULL
of	NULL
1	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
mixed	NULL
with	NULL
DNA	NULL
,	NULL
pulse-labeled	NULL
at	NULL
250	NULL
V	NULL
and	NULL
960	NULL
wFd	NULL
,	NULL
maintained	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
,	NULL
and	NULL
plated	NULL
in	NULL
100-mm	NULL
dishes	NULL
with	NULL
15	NULL
ml	NULL
of	NULL
medium	NULL
.	NULL

After	NULL
48	NULL
hr	NULL
of	NULL
culture	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
activities	NULL
were	NULL
determined	NULL
as	NULL
reported	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Quantitative	NULL
measurements	NULL
of	NULL
different	NULL
chloramphenicol	NULL
species	NULL
using	NULL
duplicate	NULL
independent	NULL
transfections	NULL
of	NULL
each	NULL
sample	NULL
were	NULL
made	NULL
with	NULL
phosphoimaging	NULL
equipment	NULL
(	NULL
Fuji	NULL
)	NULL
.	NULL

As	NULL
an	NULL
internal	NULL
control	NULL
of	NULL
transfection	NULL
efficiencies	NULL
2	NULL
ug	NULL
of	NULL
pCMV	NULL
8	NULL
(	NULL
22	NULL
)	NULL
was	NULL
included	NULL
in	NULL
all	NULL
transfections	NULL
.	NULL

B-Galactosidase	NULL
activity	NULL
was	NULL
measured	NULL
spectrophotometrically	NULL
.	NULL

This	NULL
result	NULL
showed	NULL
that	NULL
transfection	NULL
efficiency	NULL
generally	NULL
varied	NULL
less	NULL
than	NULL
10	NULL
%	NULL
and	NULL
always	NULL
less	NULL
than	NULL
15	NULL
%	NULL
;	NULL
therefore	NULL
,	NULL
no	NULL
normalization	NULL
to	NULL
this	NULL
control	NULL
was	NULL
done	NULL
.	NULL

Southern	NULL
Blot	NULL
Analysis	NULL
.	NULL

CIITA	NULL
mRNA	NULL
was	NULL
assessed	NULL
in	NULL
Southern	NULL
blots	NULL
of	NULL
PCR	NULL
products	NULL
from	NULL
cDNA	NULL
(	NULL
prepared	NULL
as	NULL
above	NULL
)	NULL
using	NULL
primers	NULL
CIITA.2	NULL
and	NULL
CIITA.3	NULL
(	NULL
TTGAGCGA-CACGGTGGCGCTGTGGGAG	NULL
)	NULL
.	NULL

Blots	NULL
were	NULL
prepared	NULL
,	NULL
hy-bridized	NULL
,	NULL
and	NULL
washed	NULL
under	NULL
high-stringency	NULL
conditions	NULL
as	NULL
described	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
(	NULL
1997	NULL
)	NULL
6331	NULL
Yeast	NULL
Two-Hybrid	NULL
System	NULL
and	NULL
-Galactosidase	NULL
Assay	NULL
.	NULL

All	NULL
yeast	NULL
manipulations	NULL
were	NULL
performed	NULL
in	NULL
strain	NULL
SFY526	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
suppliers	NULL
protocols	NULL
(	NULL
CLONTECH	NULL
)	NULL
.	NULL

All	NULL
quantitative	NULL
data	NULL
was	NULL
derived	NULL
from	NULL
three	NULL
independent	NULL
colonies	NULL
transformed	NULL
with	NULL
the	NULL
indicated	NULL
plasmid	NULL
(	NULL
s	NULL
)	NULL
.	NULL

The	NULL
B-galactosidase	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Far-Western	NULL
Blot	NULL
Analysis	NULL
.	NULL

Recombinant	NULL
proteins	NULL
from	NULL
plasmids	NULL
pHISCIITTA1I-161	NULL
,	NULL
pHISCIHITA299-1129	NULL
,	NULL
and	NULL
pFUSE	NULL
were	NULL
induced	NULL
in	NULL
host	NULL
BI21	NULL
(	NULL
DE3	NULL
)	NULL
(	NULL
Novagen	NULL
)	NULL
and	NULL
purified	NULL
by	NULL
nickel-chelate	NULL
chromatography	NULL
under	NULL
denaturing	NULL
conditions	NULL
for	NULL
CIITA-	NULL
(	NULL
299-1129	NULL
)	NULL
and	NULL
native	NULL
conditions	NULL
for	NULL
CIHITA-	NULL
(	NULL
1-161	NULL
)	NULL
and	NULL
GAL4-	NULL
(	NULL
1-147	NULL
)	NULL
(	NULL
Qiagen	NULL
,	NULL
Chatsworth	NULL
,	NULL
CA	NULL
;	NULL
protocols	NULL
7	NULL
and	NULL
5	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Western	NULL
blots	NULL
were	NULL
made	NULL
and	NULL
probed	NULL
as	NULL
described	NULL
(	NULL
24	NULL
)	NULL
except	NULL
that	NULL
5	NULL
ug	NULL
of	NULL
recombinant	NULL
protein	NULL
was	NULL
loaded	NULL
per	NULL
lane	NULL
and	NULL
protein	NULL
probes	NULL
were	NULL
*°S-radiolabeled	NULL
by	NULL
in	NULL
vitro	NULL
translation	NULL
(	NULL
TNT	NULL
reticulocyte	NULL
,	NULL
Pro-mega	NULL
)	NULL
.	NULL

RESULTS	NULL
RFX5	NULL
Activates	NULL
Transcription	NULL
When	NULL
Tethered	NULL
to	NULL
a	NULL
Heter-ologous	NULL
Promoter	NULL
in	NULL
Raji	NULL
B	NULL
Cells	NULL
.	NULL

A	NULL
series	NULL
of	NULL
expression	NULL
plasmids	NULL
were	NULL
constructed	NULL
that	NULL
fused	NULL
coding	NULL
regions	NULL
of	NULL
RFXS	NULL
to	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

The	NULL
plasmids	NULL
were	NULL
designed	NULL
to	NULL
remove	NULL
from	NULL
the	NULL
5°	NULL
end	NULL
successive	NULL
putative	NULL
functional	NULL
domains	NULL
identified	NULL
within	NULL
the	NULL
RFXS	NULL
primary	NULL
structure	NULL
including	NULL
the	NULL
DNA	NULL
binding	NULL
and	NULL
proline-rich	NULL
domains	NULL
and	NULL
the	NULL
central	NULL
region	NULL
of	NULL
the	NULL
coding	NULL
sequence	NULL
.	NULL

These	NULL
plasmids	NULL
and	NULL
the	NULL
controls	NULL
,	NULL
pBXG1	NULL
,	NULL
which	NULL
expresses	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
,	NULL
and	NULL
pBXGAL-VP	NULL
,	NULL
which	NULL
expresses	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
fused	NULL
to	NULL
the	NULL
VP16	NULL
acidic	NULL
activator	NULL
,	NULL
were	NULL
cotransfected	NULL
into	NULL
Raji	NULL
B	NULL
cells	NULL
with	NULL
the	NULL
reporter	NULL
plasmid	NULL
pGSEC	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
GAL4	NULL
binding	NULL
sites	NULL
upstream	NULL
of	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Transcription	NULL
was	NULL
activated	NULL
by	NULL
the	NULL
expression	NULL
of	NULL
two	NULL
of	NULL
these	NULL
RFXS5	NULL
fusion	NULL
proteins	NULL
corresponding	NULL
to	NULL
5	NULL
'	NULL
deletions	NULL
at	NULL
amino	NULL
acids	NULL
residues	NULL
34	NULL
and	NULL
194	NULL
in	NULL
the	NULL
open	NULL
reading	NULL
frame	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
portions	NULL
of	NULL
the	NULL
RFXS5	NULL
protein	NULL
can	NULL
activate	NULL
transcription	NULL
within	NULL
B	NULL
cells	NULL
in	NULL
a	NULL
context	NULL
other	NULL
than	NULL
that	NULL
of	NULL
the	NULL
class	NULL
II	NULL
MHC	NULL
promoter	NULL
and	NULL
that	NULL
RFXS	NULL
can	NULL
activate	NULL
transcription	NULL
from	NULL
the	NULL
reporter	NULL
construct	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
other	NULL
MHC	NULL
class	NULL
II	NULL
promoter	NULL
binding	NULL
proteins	NULL
.	NULL

Since	NULL
activity	NULL
was	NULL
maintained	NULL
after	NULL
deletion	NULL
of	NULL
the	NULL
first	NULL
194	NULL
amino	NULL
acids	NULL
of	NULL
RFX5	NULL
,	NULL
its	NULL
DNA	NULL
binding	NULL
region	NULL
was	NULL
not	NULL
required	NULL
for	NULL
transcriptional	NULL
activation	NULL
and	NULL
could	NULL
be	NULL
substituted	NULL
by	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

Furthermore	NULL
,	NULL
comparison	NULL
of	NULL
the	NULL
activities	NULL
induced	NULL
by	NULL
the	NULL
34-and	NULL
194-residue	NULL
deletion	NULL
constructs	NULL
indicates	NULL
that	NULL
stronger	NULL
transcription	NULL
activation	NULL
was	NULL
seen	NULL
with	NULL
the	NULL
194-residue	NULL
deletion	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
the	NULL
RFXS5	NULL
DNA	NULL
binding	NULL
domain	NULL
may	NULL
sequester	NULL
some	NULL
of	NULL
the	NULL
fusion	NULL
protein	NULL
to	NULL
recognition	NULL
sites	NULL
within	NULL
the	NULL
genome	NULL
and	NULL
away	NULL
from	NULL
the	NULL
reporter	NULL
plasmid	NULL
.	NULL

Transcriptional	NULL
Activation	NULL
by	NULL
the	NULL
RFX5	NULL
Activation	NULL
Domain	NULL
Is	NULL
IFN-y-Inducible	NULL
in	NULL
HeLa	NULL
Cells	NULL
.	NULL

HeLa	NULL
cells	NULL
are	NULL
well	NULL
characterized	NULL
as	NULL
a	NULL
model	NULL
system	NULL
for	NULL
IFN-y	NULL
induction	NULL
of	NULL
class	NULL
II	NULL
MHC	NULL
genes	NULL
(	NULL
26	NULL
)	NULL
.	NULL

When	NULL
the	NULL
RFXS	NULL
deletion	NULL
plasmids	NULL
were	NULL
transfected	NULL
into	NULL
HeLa	NULL
cells	NULL
,	NULL
no	NULL
transcription	NULL
from	NULL
the	NULL
reporter	NULL
gene	NULL
plasmid	NULL
was	NULL
detected	NULL
.	NULL

However	NULL
,	NULL
after	NULL
treatment	NULL
with	NULL
IFN-y	NULL
,	NULL
transcriptional	NULL
activity	NULL
in	NULL
HeLa	NULL
cells	NULL
was	NULL
observed	NULL
in	NULL
transfections	NULL
with	NULL
both	NULL
the	NULL
34-	NULL
and	NULL
194-residue	NULL
deletion	NULL
constructs	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
data	NULL
obtained	NULL
from	NULL
the	NULL
Raji	NULL
cell	NULL
transfections	NULL
RFX5-	NULL
(	NULL
194-615	NULL
)	NULL
produced	NULL
more	NULL
reporter	NULL
gene	NULL
activity	NULL
than	NULL
did	NULL
RFX5-	NULL
(	NULL
34-615	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
RFXS5	NULL
does	NULL
not	NULL
contain	NULL
an	NULL
``	NULL
activation	NULL
domain	NULL
``	NULL
since	NULL
previously	NULL
defined	NULL
activation	NULL
domains	NULL
are	NULL
constituitively	NULL
functional	NULL
.	NULL

Thus	NULL
,	NULL
either	NULL
the	NULL
RFXS	NULL
domain	NULL
is	NULL
modified	NULL
in	NULL
the	NULL
cell	NULL
after	NULL
IFN-y	NULL
treatment	NULL
or	NULL
,	NULL
alternatively	NULL
,	NULL
an	NULL
additional	NULL
factor	NULL
,	NULL
induced	NULL
or	NULL
activated	NULL
by	NULL
IFN-y	NULL
stimulation	NULL
,	NULL
might	NULL
be	NULL
required	NULL
for	NULL
transcriptinal	NULL
activation	NULL
by	NULL
the	NULL
RFXS5	NULL
fusion	NULL
protein	NULL
.	NULL

Relevantly	NULL
,	NULL
IFN-y	NULL
is	NULL
known	NULL
to	NULL
induce	NULL
the	NULL
transcription	NULL
of	NULL
CIITA	NULL
,	NULL
a	NULL
factor	NULL
that	NULL
is	NULL
essential	NULL
for	NULL
transcription	NULL
from	NULL
class	NULL
6332	NULL
Immunology	NULL
:	NULL
Scholl	NULL
et	NULL
al	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
(	NULL
1997	NULL
)	NULL
DBD	NULL
Pro	NULL
RFrxs	NULL
on-	NULL
e	NULL
%	NULL
pSV2CAT	NULL
:	NULL
z	NULL
:	NULL
:	NULL
:	NULL
f	NULL
f	NULL
-	NULL
|	NULL
$	NULL
.	NULL

Kari	NULL
}	NULL
$	NULL
o	NULL
,	NULL
F	NULL
:	NULL
f	NULL
:	NULL
o	NULL
.	NULL

wales	NULL
,	NULL
gh	NULL
___	NULL
:	NULL
hc	NULL
REx5	NULL
(	NULL
34-615	NULL
)	NULL
|	NULL
~	NULL
Xhol	NULL
i	NULL
i	NULL
‘	NULL
.	NULL

(	NULL
-194	NULL
)	NULL
:	NULL
-	NULL
0	NULL
<	NULL
+	NULL
e	NULL
__	NULL
:	NULL
RFX5	NULL
(	NULL
194-615	NULL
)	NULL
Pst	NULL
!	NULL

%	NULL
(	NULL
-318	NULL
)	NULL
F	NULL
.	NULL

sell	NULL
o	NULL
--	NULL
EcoR	NULL
!	NULL

.	NULL

(	NULL
477	NULL
)	NULL
-	NULL
&	NULL
melee	NULL
o-	NULL
%	NULL
fe	NULL
.	NULL

pBXG1	NULL
Ka	NULL
,	NULL
413-490	NULL
)	NULL
pBXGAL-VP	NULL
:	NULL
:	NULL
=	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

-	NULL
Regions	NULL
of	NULL
RFXS	NULL
that	NULL
activate	NULL
transcription	NULL
in	NULL
the	NULL
Raji	NULL
human	NULL
B	NULL
cell	NULL
line	NULL
.	NULL

A	NULL
series	NULL
of	NULL
5	NULL
``	NULL
deletions	NULL
of	NULL
the	NULL
RFXS5	NULL
coding	NULL
region	NULL
were	NULL
fused	NULL
to	NULL
the	NULL
GAL4-	NULL
(	NULL
1-147	NULL
)	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

These	NULL
plasmids	NULL
were	NULL
designed	NULL
to	NULL
sequentially	NULL
remove	NULL
putative	NULL
functional	NULL
domains	NULL
detected	NULL
in	NULL
the	NULL
primary	NULL
structure	NULL
of	NULL
RFX5	NULL
.	NULL

RFX5-	NULL
(	NULL
34-615	NULL
)	NULL
is	NULL
essentially	NULL
full-length	NULL
,	NULL
RFX5-	NULL
(	NULL
194-615	NULL
)	NULL
removes	NULL
the	NULL
DNA-binding	NULL
domain	NULL
,	NULL
RFX5-	NULL
(	NULL
318-615	NULL
)	NULL
removes	NULL
the	NULL
central	NULL
region	NULL
,	NULL
and	NULL
RFX5-	NULL
(	NULL
477-615	NULL
)	NULL
removes	NULL
the	NULL
proline-rich	NULL
region	NULL
.	NULL

Numbers	NULL
used	NULL
are	NULL
the	NULL
numbers	NULL
of	NULL
amino	NULL
acid	NULL
residues	NULL
deleted	NULL
from	NULL
the	NULL
reported	NULL
translation	NULL
initiation	NULL
codon	NULL
.	NULL

pBXGAL-VP	NULL
expresses	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
fused	NULL
to	NULL
the	NULL
acidic	NULL
activation	NULL
domain	NULL
of	NULL
VP16-	NULL
(	NULL
413-490	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
pg	NULL
of	NULL
pGSEC	NULL
alone	NULL
as	NULL
a	NULL
control	NULL
for	NULL
background	NULL
activity	NULL
by	NULL
this	NULL
reporter	NULL
construct	NULL
.	NULL

The	NULL
autoradiograph	NULL
presents	NULL
data	NULL
from	NULL
independent	NULL
duplicate	NULL
transfections	NULL
of	NULL
acetylated	NULL
chloramphenicol	NULL
species	NULL
separated	NULL
by	NULL
TLC	NULL
used	NULL
to	NULL
measure	NULL
reporter	NULL
gene	NULL
activity	NULL
.	NULL

II	NULL
MHC	NULL
promoters	NULL
(	NULL
11	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
induction	NULL
of	NULL
CIITA	NULL
message	NULL
could	NULL
be	NULL
detected	NULL
under	NULL
the	NULL
IFN-y	NULL
stimulation	NULL
conditions	NULL
used	NULL
in	NULL
these	NULL
assays	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
;	NULL
see	NULL
ref	NULL
.	NULL

11	NULL
)	NULL
.	NULL

CIITA	NULL
Is	NULL
Required	NULL
for	NULL
Transcriptional	NULL
Activation	NULL
by	NULL
RFXS	NULL
.	NULL

The	NULL
cell	NULL
line	NULL
RJ2.2.5	NULL
was	NULL
derived	NULL
by	NULL
laboratory	NULL
mutagenesis	NULL
of	NULL
+	NULL
*e	NULL
T	NULL
pSV2CAT	NULL
t	NULL
#	NULL
0	NULL
+	NULL
#	NULL
0	NULL
-	NULL
<	NULL
>	NULL
-~	NULL
@	NULL
#	NULL
#	NULL
DPACAT	NULL
o	NULL
#	NULL
»	NULL
>	NULL
-~C	NULL
#	NULL
C	NULL
_	NULL
@	NULL
*	NULL
%	NULL
~~	NULL
pBXG1	NULL
o	NULL
o~~	NULL
@	NULL
U	NULL
o	NULL
~C	NULL
»	NULL
~C	NULL
RFX5	NULL
(	NULL
34-615	NULL
)	NULL
o	NULL
<	NULL
p	NULL
»	NULL
.	NULL

»	NULL
o	NULL
#	NULL
©	NULL
®	NULL
RFX5	NULL
(	NULL
194-615	NULL
)	NULL
»	NULL
C	NULL
,	NULL
]	NULL
©	NULL
camille	NULL
massy	NULL
<	NULL
RFX5	NULL
(	NULL
318-615	NULL
)	NULL
9	NULL
.	NULL

»	NULL
.	NULL

pBXGAL-VP	NULL
Control	NULL
+IFN-Y	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Transcriptional	NULL
activity	NULL
by	NULL
RFX5-GALA	NULL
fusion	NULL
proteins	NULL
is	NULL
induced	NULL
by	NULL
IFN-y	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

Autoradiographs	NULL
of	NULL
reporter	NULL
gene	NULL
activity	NULL
from	NULL
transfected	NULL
control	NULL
HeLa	NULL
cells	NULL
and	NULL
HeLa	NULL
cells	NULL
treated	NULL
with	NULL
IFN-y	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
pug	NULL
of	NULL
the	NULL
indicated	NULL
plasmids	NULL
.	NULL

Samples	NULL
transfected	NULL
with	NULL
GALA	NULL
fusion	NULL
proteins	NULL
were	NULL
cotransfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
pGSEC	NULL
.	NULL

the	NULL
B	NULL
cell	NULL
lymphoma	NULL
line	NULL
Raji	NULL
.	NULL

This	NULL
line	NULL
is	NULL
globally	NULL
defective	NULL
in	NULL
MHC	NULL
class	NULL
II	NULL
transcription	NULL
due	NULL
to	NULL
mutations	NULL
in	NULL
both	NULL
copies	NULL
of	NULL
CIITA	NULL
and	NULL
serves	NULL
as	NULL
a	NULL
CIITA	NULL
negative	NULL
background	NULL
.	NULL

Transcriptional	NULL
activation	NULL
by	NULL
RFX5-	NULL
(	NULL
34-615	NULL
)	NULL
and	NULL
RFX5-	NULL
(	NULL
194-615	NULL
)	NULL
was	NULL
detected	NULL
in	NULL
transfection	NULL
of	NULL
RJ2.2.5	NULL
only	NULL
when	NULL
an	NULL
expression	NULL
plasmid	NULL
encoding	NULL
CIITA	NULL
was	NULL
included	NULL
and	NULL
not	NULL
in	NULL
controls	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
CIITA	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
CIITA	NULL
is	NULL
required	NULL
for	NULL
the	NULL
activity	NULL
directed	NULL
by	NULL
RFXS	NULL
.	NULL

Direct	NULL
Protein-Protein	NULL
Interaction	NULL
Between	NULL
CIITA	NULL
and	NULL
RFX5	NULL
.	NULL

The	NULL
requirement	NULL
for	NULL
CHTA	NULL
in	NULL
transcriptional	NULL
activation	NULL
mediated	NULL
through	NULL
RFXS5	NULL
could	NULL
be	NULL
explained	NULL
by	NULL
a	NULL
direct	NULL
interaction	NULL
between	NULL
these	NULL
two	NULL
factors	NULL
.	NULL

Two	NULL
systems	NULL
were	NULL
employed	NULL
to	NULL
demonstrate	NULL
this	NULL
interaction	NULL
.	NULL

(	NULL
?	NULL
)	NULL

The	NULL
yeast	NULL
two-hybrid	NULL
system	NULL
was	NULL
employed	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Three	NULL
of	NULL
the	NULL
GAL4	NULL
RFXS	NULL
inserts	NULL
in	NULL
pBXG1	NULL
[	NULL
RFX5-	NULL
(	NULL
34-615	NULL
)	NULL
,	NULL
-	NULL
(	NULL
194-615	NULL
)	NULL
,	NULL
and	NULL
-	NULL
(	NULL
318-615	NULL
)	NULL
]	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
yeast	NULL
expression	NULL
plasmid	NULL
pGBT9	NULL
,	NULL
and	NULL
the	NULL
full-length	NULL
CIHIHTA	NULL
coding	NULL
region	NULL
was	NULL
inserted	NULL
into	NULL
pGAD424	NULL
.	NULL

After	NULL
transformation	NULL
into	NULL
yeast	NULL
,	NULL
an	NULL
interaction	NULL
was	NULL
detected	NULL
between	NULL
CIITA	NULL
and	NULL
the	NULL
fusion	NULL
protein	NULL
encoding	NULL
residues	NULL
194-615	NULL
of	NULL
RFX5	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Unlike	NULL
the	NULL
mammalian	NULL
cotransfection	NULL
experiments	NULL
,	NULL
no	NULL
activity	NULL
was	NULL
detected	NULL
for	NULL
the	NULL
largest	NULL
RFXS5	NULL
region	NULL
corresponding	NULL
to	NULL
amino	NULL
acids	NULL
34-615	NULL
.	NULL

Furthermore	NULL
,	NULL
when	NULL
yeast	NULL
were	NULL
transformed	NULL
with	NULL
the	NULL
pGBT9	NULL
derivatives	NULL
alone	NULL
,	NULL
no	NULL
B-galactosidase	NULL
activity	NULL
was	NULL
detected	NULL
,	NULL
confirming	NULL
that	NULL
RFX5	NULL
can	NULL
not	NULL
activate	NULL
transcription	NULL
alone	NULL
.	NULL

(	NULL
#	NULL
)	NULL
Interaction	NULL
between	NULL
CIITA	NULL
and	NULL
RFXS	NULL
was	NULL
also	NULL
detected	NULL
in	NULL
vitro	NULL
by	NULL
the	NULL
Far-Western	NULL
technique	NULL
.	NULL

Three	NULL
recombinant	NULL
proteins	NULL
that	NULL
included	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
CHITA	NULL
(	NULL
residues	NULL
16-147	NULL
)	NULL
,	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
CHTA	NULL
(	NULL
residues	NULL
299-1129	NULL
)	NULL
,	NULL
and	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
residues	NULL
1-147	NULL
)	NULL
were	NULL
expressed	NULL
in	NULL
bacteria	NULL
in	NULL
a	NULL
vector	NULL
that	NULL
encoded	NULL
an	NULL
N-terminal	NULL
histidine	NULL
affinity	NULL
tag	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
then	NULL
purified	NULL
by	NULL
nickel-chelate	NULL
Immunology	NULL
:	NULL
Scholl	NULL
et	NULL
al	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
(	NULL
1997	NULL
)	NULL
6333	NULL
~-~	NULL
@	NULL
¢0	NULL
+-~	NULL
@	NULL
+8	NULL
pBXGAL-VP	NULL
~~	NULL
@	NULL
#	NULL
0	NULL
B+	NULL
t+	NULL
dink	NULL
*	NULL
.	NULL

®	NULL
.	NULL

*	NULL
10ug	NULL
e	NULL
~	NULL
+-~0	NULL
%	NULL
-	NULL
RFX5	NULL
(	NULL
34-615	NULL
)	NULL
@	NULL
.	NULL

@	NULL
.	NULL

5	NULL
u	NULL
-	NULL
@	NULL
F	NULL
|	NULL
C	NULL
-~	NULL
S	NULL
.	NULL

&	NULL
e-~C	NULL
%	NULL
1089	NULL
_	NULL
-	NULL
RFX5	NULL
(	NULL
194-615	NULL
)	NULL
a	NULL
L	NULL
,	NULL
.	NULL

.	NULL

5ug	NULL
o	NULL
~	NULL
+	NULL
~	NULL
Control	NULL
+pCMVCIITA	NULL
~	NULL
FiG	NULL
.	NULL

3	NULL
.	NULL

Transcriptional	NULL
activity	NULL
by	NULL
RFX4-GAL4	NULL
fusion	NULL
proteins	NULL
in	NULL
RJ2.2.5	NULL
cells	NULL
required	NULL
CIITA	NULL
.	NULL

Autoradiographs	NULL
of	NULL
reporter	NULL
gene	NULL
activity	NULL
from	NULL
RJ2.2.5	NULL
cells	NULL
cotransfected	NULL
with	NULL
the	NULL
indicated	NULL
plasmids	NULL
and	NULL
10	NULL
ug	NULL
of	NULL
pGSEC	NULL
and	NULL
cotransfections	NULL
that	NULL
also	NULL
included	NULL
10	NULL
pg	NULL
of	NULL
pCMVCIITA	NULL
.	NULL

chromatography	NULL
,	NULL
refolded	NULL
on	NULL
replicate	NULL
membranes	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
*°S-labeled	NULL
in	NULL
vitro-translated	NULL
RFXS	NULL
regions	NULL
RFX5-	NULL
(	NULL
194-615	NULL
)	NULL
and	NULL
RFX5-	NULL
(	NULL
318-615	NULL
)	NULL
.	NULL

As	NULL
a	NULL
positive	NULL
control	NULL
human	NULL
TAF7O	NULL
was	NULL
included	NULL
as	NULL
a	NULL
probe	NULL
since	NULL
it	NULL
interacts	NULL
with	NULL
the	NULL
N-terminal	NULL
acidic	NULL
activation	NULL
domain	NULL
of	NULL
CIITA	NULL
(	NULL
28	NULL
)	NULL
.	NULL

An	NULL
interaction	NULL
in	NULL
the	NULL
test	NULL
samples	NULL
was	NULL
detected	NULL
between	NULL
the	NULL
C-terminal	NULL
region	NULL
of	NULL
CIITA	NULL
,	NULL
residues	NULL
299-1129	NULL
,	NULL
and	NULL
RFX35	NULL
,	NULL
residues	NULL
194-615	NULL
,	NULL
as	NULL
well	NULL
as	NULL
between	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
CIITA	NULL
,	NULL
residues	NULL
1-161	NULL
,	NULL
and	NULL
TAF7O	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

DISCUSSION	NULL
The	NULL
isolation	NULL
of	NULL
genes	NULL
encoding	NULL
transcription	NULL
factors	NULL
responsible	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
genes	NULL
by	NULL
expression	NULL
and	NULL
complementation	NULL
screening	NULL
techniques	NULL
permits	NULL
experiments	NULL
designed	NULL
to	NULL
elucidate	NULL
the	NULL
mechanisms	NULL
through	NULL
which	NULL
these	NULL
proteins	NULL
function	NULL
.	NULL

Initial	NULL
results	NULL
from	NULL
a	NULL
functional	NULL
assay	NULL
using	NULL
GAL4	NULL
fusion	NULL
proteins	NULL
suggested	NULL
that	NULL
a	NULL
transcriptional	NULL
``	NULL
activation	NULL
domain	NULL
``	NULL
was	NULL
present	NULL
in	NULL
RFXS	NULL
.	NULL

However	NULL
,	NULL
subse-	NULL
RFXS	NULL
(	NULL
318-615	NULL
)	NULL
+	NULL
CIITA	NULL
RFX5	NULL
(	NULL
194-615	NULL
)	NULL
+	NULL
CIITA	NULL
RFX5	NULL
(	NULL
34-615	NULL
)	NULL
+	NULL
CIITA	NULL
RFX5	NULL
(	NULL
318-615	NULL
)	NULL
RFX5	NULL
(	NULL
194-615	NULL
)	NULL
RFXS	NULL
(	NULL
34-615	NULL
)	NULL
pGBTS	NULL
pTD-1	NULL
+	NULL
pVa3	NULL
I	NULL
-	NULL
a	NULL
E	NULL
100	NULL
7	NULL
]	NULL
1000	NULL
-I	NULL
10000	NULL
B-Gal	NULL
Activity	NULL
(	NULL
Miller	NULL
units	NULL
)	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Interaction	NULL
between	NULL
RFXS	NULL
and	NULL
CIITA	NULL
detected	NULL
in	NULL
yeast	NULL
.	NULL

Histograms	NULL
depict	NULL
B-galactosidase	NULL
reporter	NULL
gene	NULL
activity	NULL
in	NULL
yeast	NULL
extracts	NULL
from	NULL
cells	NULL
transformed	NULL
with	NULL
RFX5S-GAL4	NULL
fusion	NULL
protein	NULL
expression	NULL
plasmids	NULL
or	NULL
cotransformation	NULL
that	NULL
included	NULL
a	NULL
plasmid	NULL
for	NULL
expression	NULL
of	NULL
CIITA	NULL
fused	NULL
to	NULL
the	NULL
GAL4	NULL
activation	NULL
domain	NULL
.	NULL

All	NULL
data	NULL
represent	NULL
the	NULL
mean	NULL
activity	NULL
detected	NULL
in	NULL
triplicate	NULL
transformants	NULL
.	NULL

Individual	NULL
measurements	NULL
were	NULL
within	NULL
5	NULL
%	NULL
of	NULL
each	NULL
other	NULL
.	NULL

pGBT9	NULL
encodes	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
alone	NULL
.	NULL

pTD-1	NULL
used	NULL
in	NULL
the	NULL
positive	NULL
control	NULL
encodes	NULL
a	NULL
fusion	NULL
protein	NULL
made	NULL
up	NULL
of	NULL
amino	NULL
acids	NULL
84-708	NULL
of	NULL
simian	NULL
virus	NULL
40	NULL
large	NULL
tumor	NULL
antigen	NULL
and	NULL
GALA	NULL
activation	NULL
domain	NULL
and	NULL
pVa3	NULL
encodes	NULL
a	NULL
fusion	NULL
protein	NULL
made	NULL
up	NULL
of	NULL
GALA	NULL
DNA	NULL
binding	NULL
domain	NULL
and	NULL
amino	NULL
acids	NULL
72-350	NULL
of	NULL
p53	NULL
with	NULL
which	NULL
the	NULL
simian	NULL
virus	NULL
40T	NULL
antigen	NULL
interacts	NULL
.	NULL

quent	NULL
data	NULL
from	NULL
this	NULL
system	NULL
when	NULL
transfected	NULL
into	NULL
other	NULL
cell	NULL
types	NULL
indicated	NULL
first	NULL
that	NULL
this	NULL
region	NULL
of	NULL
RFXS	NULL
did	NULL
not	NULL
function	NULL
in	NULL
all	NULL
cell	NULL
types	NULL
and	NULL
then	NULL
that	NULL
cooperation/interaction	NULL
with	NULL
CIITA	NULL
was	NULL
required	NULL
for	NULL
this	NULL
activity	NULL
.	NULL

Finally	NULL
,	NULL
a	NULL
direct	NULL
interaction	NULL
was	NULL
detected	NULL
between	NULL
RFX5	NULL
and	NULL
CIITA	NULL
both	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
with	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
assay	NULL
and	NULL
biochemically	NULL
by	NULL
far-	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
RFXS5	NULL
and	NULL
CHITA	NULL
can	NULL
form	NULL
a	NULL
complex	NULL
that	NULL
is	NULL
capable	NULL
of	NULL
activating	NULL
transcription	NULL
.	NULL

CIITA	NULL
may	NULL
function	NULL
as	NULL
a	NULL
coactivator	NULL
,	NULL
binding	NULL
together	NULL
through	NULL
protein-protein	NULL
interactions	NULL
RFXS5	NULL
and	NULL
other	NULL
class	NULL
II	NULL
MHC	NULL
promoter	NULL
bound	NULL
DNA	NULL
binding	NULL
proteins	NULL
including	NULL
at	NULL
least	NULL
those	NULL
bound	NULL
to	NULL
the	NULL
TATA	NULL
box	NULL
.	NULL

Other	NULL
interactions	NULL
may	NULL
influence	NULL
the	NULL
association	NULL
of	NULL
CIITA	NULL
with	NULL
class	NULL
II	NULL
MHC	NULL
promoters	NULL
.	NULL

First	NULL
,	NULL
there	NULL
are	NULL
multiple	NULL
cis	NULL
elements	NULL
that	NULL
when	NULL
mutated	NULL
reduce	NULL
transcription	NULL
from	NULL
class	NULL
II	NULL
MHC	NULL
promoters	NULL
,	NULL
including	NULL
the	NULL
X	NULL
and	NULL
Y	NULL
box	NULL
,	NULL
the	NULL
J	NULL
and	NULL
S	NULL
elements	NULL
,	NULL
and	NULL
an	NULL
octamer	NULL
element	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

Unless	NULL
these	NULL
recognition	NULL
sites	NULL
bind	NULL
factors	NULL
whose	NULL
expression	NULL
specifically	NULL
correlates	NULL
with	NULL
class	NULL
II	NULL
transcription	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
they	NULL
also	NULL
ultimately	NULL
function	NULL
through	NULL
CIITA	NULL
.	NULL

Additionally	NULL
,	NULL
cooperative	NULL
binding	NULL
of	NULL
multiple	NULL
factors	NULL
to	NULL
class	NULL
II	NULL
promoters	NULL
has	NULL
been	NULL
demonstrated	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
CHHTA	NULL
may	NULL
tie	NULL
together	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
several	NULL
DNA	NULL
elements	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
the	NULL
DRA	NULL
promoter	NULL
,	NULL
the	NULL
most	NULL
strongly	NULL
transcribed	NULL
of	NULL
the	NULL
class	NULL
II	NULL
promoters	NULL
,	NULL
moreover	NULL
,	NULL
an	NULL
additional	NULL
proximal	NULL
element	NULL
,	NULL
OCT	NULL
,	NULL
«	NULL
¢	NULL
\a	NULL
C	NULL
o	NULL
&	NULL
C	NULL
So	NULL
&	NULL
So	NULL
£	NULL
CVC	NULL
CVSS	NULL
&	NULL
S	NULL
«	NULL
``	NULL
V	NULL
H	NULL
C	NULL
CEC	NULL
F	NULL
F	NULL
C	NULL
F	NULL
E	NULL
\	NULL
94-67-	NULL
RFX5-318	NULL
hTAF7O	NULL
Probe	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Detection	NULL
of	NULL
an	NULL
interaction	NULL
between	NULL
RFXS5	NULL
and	NULL
CIITA	NULL
by	NULL
far-Western	NULL
blot	NULL
analysis	NULL
.	NULL

Recombinant	NULL
proteins	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
were	NULL
electro-phoresed	NULL
and	NULL
blotted	NULL
on	NULL
quadruplicate	NULL
gels	NULL
.	NULL

Proteins	NULL
were	NULL
refolded	NULL
on	NULL
the	NULL
membranes	NULL
and	NULL
probed	NULL
with	NULL
the	NULL
indicated	NULL
radiolabeled	NULL
in	NULL
vitro-translated	NULL
proteins	NULL
.	NULL

6334	NULL
Immunology	NULL
:	NULL
Scholl	NULL
et	NULL
al	NULL
.	NULL

recruits	NULL
the	NULL
protein	NULL
OCT	NULL
2	NULL
and	NULL
,	NULL
through	NULL
OCT2	NULL
,	NULL
BOB1	NULL
,	NULL
which	NULL
interacts	NULL
with	NULL
the	NULL
TATA	NULL
box	NULL
binding	NULL
protein	NULL
complex	NULL
.	NULL

Synergy	NULL
in	NULL
binding	NULL
may	NULL
stabilize	NULL
interactions	NULL
with	NULL
RFX5	NULL
,	NULL
CIITA	NULL
,	NULL
or	NULL
both	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
transcription	NULL
generated	NULL
by	NULL
the	NULL
interaction	NULL
of	NULL
the	NULL
RFXS5-GAL4	NULL
fusion	NULL
proteins	NULL
was	NULL
much	NULL
less	NULL
than	NULL
that	NULL
initiated	NULL
from	NULL
the	NULL
DPA	NULL
proximal	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
or	NULL
that	NULL
detected	NULL
when	NULL
the	NULL
CIITA	NULL
activation	NULL
domain	NULL
was	NULL
fused	NULL
directly	NULL
to	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
region	NULL
.	NULL

This	NULL
finding	NULL
may	NULL
be	NULL
a	NULL
further	NULL
indication	NULL
that	NULL
additional	NULL
interaction	NULL
(	NULL
s	NULL
)	NULL
to	NULL
those	NULL
with	NULL
RFX5	NULL
are	NULL
required	NULL
for	NULL
full	NULL
recruitment	NULL
of	NULL
CIITA	NULL
to	NULL
or	NULL
subsequent	NULL
activation	NULL
of	NULL
the	NULL
MHC	NULL
promoter	NULL
.	NULL

CIITA	NULL
is	NULL
present	NULL
in	NULL
higher-order	NULL
multiprotein	NULL
complexes	NULL
present	NULL
on	NULL
MHC	NULL
class	NULL
II	NULL
promoters	NULL
(	NULL
13	NULL
)	NULL
,	NULL
and	NULL
although	NULL
it	NULL
is	NULL
required	NULL
for	NULL
MHC	NULL
class	NULL
II	NULL
transcription	NULL
and	NULL
encodes	NULL
a	NULL
strong	NULL
acidic	NULL
activation	NULL
domain	NULL
,	NULL
it	NULL
does	NULL
not	NULL
bind	NULL
DNA	NULL
.	NULL

Conversely	NULL
,	NULL
RFX5	NULL
encodes	NULL
a	NULL
DNA	NULL
binding	NULL
domain	NULL
that	NULL
recognizes	NULL
a	NULL
DNA	NULL
element	NULL
unique	NULL
to	NULL
MHC	NULL
class	NULL
II	NULL
genes	NULL
,	NULL
the	NULL
X	NULL
box	NULL
.	NULL

Thus	NULL
,	NULL
CIITA	NULL
functions	NULL
as	NULL
a	NULL
coactivator	NULL
through	NULL
specific	NULL
protein	NULL
interactions	NULL
with	NULL
RFX5	NULL
.	NULL

The	NULL
role	NULL
for	NULL
RFXS5	NULL
in	NULL
this	NULL
model	NULL
is	NULL
to	NULL
lend	NULL
promoter	NULL
specificity	NULL
to	NULL
this	NULL
complex	NULL
through	NULL
X-box-specific	NULL
recognition	NULL
by	NULL
its	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

The	NULL
role	NULL
of	NULL
CIITA	NULL
then	NULL
is	NULL
to	NULL
activate	NULL
transcription	NULL
via	NULL
its	NULL
N-terminal	NULL
acidic	NULL
domain	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
CA47554	NULL
and	NULL
by	NULL
fellowships	NULL
of	NULL
the	NULL
American	NULL
Cancer	NULL
Society	NULL
to	NULL
T.S	NULL
.	NULL

and	NULL
of	NULL
the	NULL
Irvington	NULL
Foundation	NULL
for	NULL
Medical	NULL
Research	NULL
to	NULL
S.K.M	NULL
.	NULL

1	NULL
.	NULL

Mach	NULL
,	NULL
B.	NULL
,	NULL
Steimle	NULL
,	NULL
V.	NULL
&	NULL
Reith	NULL
,	NULL
W.	NULL
(	NULL
1994	NULL
)	NULL
Immunol	NULL
.	NULL

Rev	NULL
.	NULL

138	NULL
,	NULL
207-221	NULL
.	NULL

2	NULL
.	NULL

-	NULL
Benichou	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Strominger	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

88	NULL
,	NULL
4285-4288	NULL
.	NULL

3	NULL
.	NULL

Hume	NULL
,	NULL
C.	NULL
R.	NULL
&	NULL
Lee	NULL
,	NULL
J.	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
Hum	NULL
.	NULL

Immunol	NULL
.	NULL

26	NULL
,	NULL
288-309	NULL
.	NULL

4	NULL
.	NULL

Hume	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
Shookster	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Collins	NULL
,	NULL
N.	NULL
,	NULL
O'Reilly	NULL
,	NULL
R.	NULL
&	NULL
Lee	NULL
,	NULL
J.	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
Hum	NULL
.	NULL

Immunol	NULL
.	NULL

25	NULL
,	NULL
1-11	NULL
.	NULL

5	NULL
.	NULL

Yang	NULL
,	NULL
Z.	NULL
,	NULL
Acolla	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
Pious	NULL
,	NULL
D.	NULL
,	NULL
Zegers	NULL
,	NULL
B.	NULL
J.	NULL
M.	NULL
&	NULL
Strominger	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1988	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

7	NULL
,	NULL
1965-1972	NULL
.	NULL

6	NULL
.	NULL

-	NULL
Hauber	NULL
,	NULL
I.	NULL
,	NULL
Gulle	NULL
,	NULL
H.	NULL
,	NULL
Wolf	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Maris	NULL
,	NULL
M.	NULL
,	NULL
Eggenbauer	NULL
,	NULL
H.	NULL
&	NULL
Eibl	NULL
,	NULL
M.	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181	NULL
,	NULL
1411-1423	NULL
.	NULL

7	NULL
.	NULL

Douhan	NULL
,	NULL
J.	NULL
,	NULL
Hauber	NULL
,	NULL
I.	NULL
,	NULL
Eibl	NULL
,	NULL
M.	NULL
M.	NULL
&	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183	NULL
,	NULL
1063-1069	NULL
.	NULL

8	NULL
.	NULL

Steimle	NULL
,	NULL
V.	NULL
,	NULL
Otten	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Zufferey	NULL
,	NULL
M.	NULL
&	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Cell	NULL
75	NULL
,	NULL
135-146	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
(	NULL
1997	NULL
)	NULL
Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
Boothby	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Finn	NULL
,	NULL
P.	NULL
W.	NULL
,	NULL
Davidon	NULL
,	NULL
R.	NULL
,	NULL
Nabavi	NULL
,	NULL
N.	NULL
,	NULL
Zeleznik-Le	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
Ting	NULL
,	NULL
J.	NULL
P.-Y	NULL
.	NULL

&	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
247	NULL
,	NULL
1581-1584	NULL
.	NULL

Sugawara	NULL
,	NULL
M.	NULL
,	NULL
Scholl	NULL
,	NULL
T.	NULL
,	NULL
Ponath	NULL
,	NULL
P.	NULL
D.	NULL
&	NULL
Strominger	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:8438-8450	NULL
.	NULL

Steimle	NULL
,	NULL
V.	NULL
,	NULL
Siegrist	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Mottet	NULL
,	NULL
O.	NULL
,	NULL
Lisowska-Grospierre	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Science	NULL
265	NULL
,	NULL
106-109	NULL
.	NULL

Silacci	NULL
,	NULL
P.	NULL
,	NULL
Mottet	NULL
,	NULL
A.	NULL
,	NULL
Steimle	NULL
,	NULL
V.	NULL
,	NULL
Reith	NULL
,	NULL
W.	NULL
&	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180	NULL
,	NULL
1329-1336	NULL
.	NULL

Riley	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Westerhide	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Price	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Brown	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

&	NULL
Boss	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
Immunity	NULL
2	NULL
,	NULL
533-543	NULL
.	NULL

Zhou	NULL
,	NULL
H.	NULL
&	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
Immunity	NULL
2	NULL
,	NULL
545-553	NULL
.	NULL

Steimle	NULL
,	NULL
V.	NULL
,	NULL
Durand	NULL
,	NULL
B.	NULL
,	NULL
Barras	NULL
,	NULL
E.	NULL
,	NULL
Zufferey	NULL
,	NULL
M.	NULL
,	NULL
Hadam	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Reith	NULL
,	NULL
W.	NULL
(	NULL
1995	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

9	NULL
,	NULL
1021-1032	NULL
.	NULL

Reith	NULL
,	NULL
W.	NULL
,	NULL
Barras	NULL
,	NULL
E.	NULL
,	NULL
Satola	NULL
,	NULL
S.	NULL
,	NULL
Kobr	NULL
,	NULL
M.	NULL
,	NULL
Reinhart	NULL
,	NULL
C.	NULL
,	NULL
Herrero	NULL
Sanchez	NULL
,	NULL
C.	NULL
&	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
,	NULL
4200-4204	NULL
.	NULL

Reith	NULL
,	NULL
W.	NULL
,	NULL
Ucla	NULL
,	NULL
C.	NULL
,	NULL
Barras	NULL
,	NULL
E.	NULL
,	NULL
Gaud	NULL
,	NULL
A.	NULL
,	NULL
Durand	NULL
,	NULL
B.	NULL
,	NULL
Herrero-Sanchez	NULL
,	NULL
C.	NULL
,	NULL
Kobr	NULL
,	NULL
M.	NULL
&	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
1230-1244	NULL
.	NULL

Siegrist	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Durand	NULL
,	NULL
B.	NULL
,	NULL
Emery	NULL
,	NULL
P.	NULL
,	NULL
David	NULL
,	NULL
E.	NULL
,	NULL
Hearing	NULL
,	NULL
P.	NULL
,	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Reith	NULL
,	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
,	NULL
6375-6384	NULL
.	NULL

Accolla	NULL
,	NULL
R.	NULL
S.	NULL
(	NULL
1983	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

157	NULL
,	NULL
1053-1058	NULL
.	NULL

Scholl	NULL
,	NULL
T.	NULL
,	NULL
Stevens	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Mahanta	NULL
,	NULL
S.	NULL
&	NULL
Strominger	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

156	NULL
,	NULL
1448-1457	NULL
.	NULL

Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Moffat	NULL
,	NULL
L.	NULL
F.	NULL
&	NULL
Howard	NULL
,	NULL
B.	NULL
H.	NULL
(	NULL
1982	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2	NULL
,	NULL
1044-1051	NULL
.	NULL

MacGregor	NULL
,	NULL
G.	NULL
R.	NULL
&	NULL
Caskey	NULL
,	NULL
C.	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
2365	NULL
.	NULL

Scholl	NULL
,	NULL
T.	NULL
,	NULL
Pitcock	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Jones	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Immunogenetics	NULL
36	NULL
,	NULL
255-263	NULL
.	NULL

Wu	NULL
,	NULL
J.	NULL
Y	NULL
.	NULL

&	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1993	NULL
)	NULL
Cell	NULL
75	NULL
,	NULL
1061-1070	NULL
.	NULL

Sadowski	NULL
,	NULL
I	NULL
.	NULL

&	NULL
Ptashne	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
7539-7540	NULL
.	NULL

Boss	NULL
,	NULL
J.	NULL
M.	NULL
&	NULL
Strominger	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83	NULL
,	NULL
9139-9143	NULL
.	NULL

Fields	NULL
,	NULL
S.	NULL
&	NULL
Song	NULL
,	NULL
O	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
340	NULL
,	NULL
245-246	NULL
.	NULL

Sanjeev	NULL
,	NULL
K.	NULL
Mahanta	NULL
,	NULL
Scholl	NULL
,	NULL
T.	NULL
,	NULL
Yang	NULL
,	NULL
F.-C.	NULL
&	NULL
Strominger	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1997	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
,	NULL
6324-6329	NULL
.	NULL

Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
&	NULL
Cara	NULL
,	NULL
C.J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

10	NULL
,	NULL
13-50	NULL
.	NULL

Sugawara	NULL
,	NULL
M.	NULL
,	NULL
Scholl	NULL
,	NULL
T.	NULL
,	NULL
Ponath	NULL
,	NULL
P.	NULL
&	NULL
Strominger	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
8438-8450	NULL
.	NULL

Durand	NULL
,	NULL
B.	NULL
,	NULL
Kobr	NULL
,	NULL
M.	NULL
,	NULL
Reith	NULL
,	NULL
W.	NULL
&	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
6839-6847	NULL
.	NULL

Moreno	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
Emery	NULL
,	NULL
P.	NULL
,	NULL
West	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Durand	NULL
,	NULL
B.	NULL
,	NULL
Reith	NULL
,	NULL
W.	NULL
,	NULL
Mach	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Boss	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

155	NULL
,	NULL
4313-4321	NULL
.	NULL

